Persistence of SARS-CoV-2 virus RNA in feces: A case series of children
- PMID: 32546439
- PMCID: PMC7275988
- DOI: 10.1016/j.jiph.2020.05.025
Persistence of SARS-CoV-2 virus RNA in feces: A case series of children
Abstract
Aims: To determine how long SARS-CoV-2 virus RNA persists in fecal specimens in children with COVID-19.
Methods: Retrospectively, ten children with confirmed COVID-19 in the Jinan Infectious Disease Hospital Affiliated to Shandong University were enrolled between January 23, 2020 to March 9, 2020. Epidemiological, clinical, laboratory, and radiological characteristics of the children were analyzed. RT-PCR assays were performed to detect the SARS-CoV-2 virus RNA in the respiratory tract and fecal specimens in the follow-up after discharge.
Results: Among ten patients, five (50%) were asymptomatic and five (50%) showed mild symptoms of respiratory illness. The average age of asymptomatic children was younger than that of symptomatic children (p = 0.03). The decreases in white blood cell (WBC) (p = 0.03) and lymphocyte (p = 0.03) counts were more severe in symptomatic patients than those in asymptomatic patients. During the follow-up examination after discharge, seven out of ten patients contained SARS-CoV-2 virus RNA in their fecal specimens, despite all patients showed negative results in respiratory tract specimens. One out of those seven patients relapsed. The median time from onset to being negative results in respiratory tract and fecal specimens was 9 days and 34.43 days, respectively.
Conclusions: SARS-CoV-2 virus RNA persists much longer in the gastrointestinal (GI) tract than that in respiratory tract.
Keywords: COVID-19; Children; Fecal specimen; SARS-CoV-2.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.
Figures
References
-
- World Health Organization. WHO statement regarding cluster of pneumonia cases in Wuhan, China. Available: https://www.who.int/china/news/detail/09-01-2020-who-statement-regarding.... [Accessed 11 January 2020].
-
- National Health Commission of The People’s Republic of China. Interim protocol of diagnosis and treatment of 2019 novel coronavirus-associated pneumonia (the second version). Available: http://www.nhc.gov.cn/jkj/s3577/202001/c67cfe29ecf1470e8c7fc47d3b751e88.... [Accessed 18 January 2020].
-
- WHO. Coronavirus. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. [Accessed 11 February 2020].
-
- National Health Commission of People’s Republic of China. Chinese clinical guidance for COVID-19 pneumonia diagnosis and treatment(7th version) http://www.nhc.gov.cn/yzygj/s7653p/202003/46c9294a7dfe4cef80dc7f5912eb19....
-
- The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team, China CDC The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases in China. Zhong hua Liu Xing Bing Xue Za Zhi. 2020;41(February (2)):145–151. doi: 10.3760/cma.j.issn.0254-6450.2020.02.003. - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
